EagleClaw Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01M | Hold |
|
|||||
|
2025
Q1 | $2.78M | Sell |
|
|||||
|
2024
Q4 | $2.45M | Buy |
|
|||||
|
2024
Q3 | $2.58M | Sell |
|
|||||
|
2024
Q2 | $2.59M | Hold |
|
|||||
|
2024
Q1 | $2.35M | Buy |
|
|||||
|
2023
Q4 | $2.39M | Buy |
|
|||||
|
2023
Q3 | $2.38M | Buy |
|
|||||
|
2023
Q2 | $2.28M | Sell |
|
|||||
|
2023
Q1 | $2.15M | Sell |
|
|||||
|
2022
Q4 | $2.21M | Sell |
|
|||||
|
2022
Q3 | $1.86M | Sell |
|
|||||
|
2022
Q2 | $2.1M | Buy |
|
|||||
|
2022
Q1 | $2.18M | Sell |
|
|||||
|
2021
Q4 | $2.18M | Buy |
|
|||||
|
2021
Q3 | $2M | Buy |
|
|||||
|
2021
Q2 | $2.18M | Buy |
|
|||||
|
2021
Q1 | $1.88M | Hold |
|
|||||
|
2020
Q4 | $2.08M | Hold |
|
|||||
|
2020
Q3 | $1.91M | Buy |
|
|||||
|
2020
Q2 | $1.84M | Sell |
|
|||||
|
2020
Q1 | $1.81M | Sell |
|
|||||
|
2019
Q4 | $2.09M | Hold |
|
|||||
|
2019
Q3 | $1.92M | Buy |
|
|||||
|
2019
Q2 | $1.98M | Sell |
|
|||||
|
2019
Q1 | $2.09M | Buy |
|
|||||
|
2018
Q4 | $1.82M | Hold |
|
|||||
|
2018
Q3 | $1.83M | Buy |
|
|||||
|
2018
Q2 | $1.57M | Buy |
|
|||||
|
2018
Q1 | $1.66M | Buy |
|
|||||
|
2017
Q4 | $1.67M | Buy |
|
|||||
|
2017
Q3 | $1.52M | Sell |
|
|||||
|
2017
Q2 | $1.52M | Hold |
|
|||||
|
2017
Q1 | $1.36M | Sell |
|
|||||
|
2016
Q4 | $1.34M | Hold |
|
|||||
|
2016
Q3 | $1.45M | Buy |
|
|||||
|
2016
Q2 | $1.51M | Hold |
|
|||||
|
2016
Q1 | $1.32M | Sell |
|
|||||
|
2015
Q4 | $1.6M | Sell |
|
|||||
|
2015
Q3 | $1.72M | Sell |
|
|||||
|
2015
Q2 | $1.88M | Sell |
|
|||||
|
2015
Q1 | $1.9M | Sell |
|
|||||
|
2014
Q4 | $1.79M | Sell |
|
|||||
|
2014
Q3 | $1.83M | Buy |
|
|||||
|
2014
Q2 | $1.75M | Buy |
|
|||||
|
2014
Q1 | $1.61M | Buy |
|